A2A Pharmaceuticals, Inc. - 20 Apr 2023 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)

Role
10%+ Owner
Signature
Edward Painter
Issuer symbol
BMEA
Transactions as of
20 Apr 2023
Net transactions value
-$5,823,760
Form type
4
Filing time
26 Apr 2023, 08:36:59 UTC
Previous filing
06 Apr 2023
Next filing
10 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMEA Common Stock Sale $5,823,760 -200,000 -4.9% $29.12 3,900,000 20 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A total of 200,000 shares were sold at an average price of 29.1188 in multiple transactions in a range of 28.85 to 29.495. Details of the specific transactions are available upon request